Launch week offerEnds in00h00m00s

annual Promonthly Pro

ELLEN HARTENBACH

Professor and Chair

University of Wisconsin School of Medicine and Public Health

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in United States

About

Ellen Hartenbach is a Professor and Chair at the University of Wisconsin Health, United States. Her research interests encompass gynecologic oncology, particularly focusing on postoperative complications, cancer genetics, and the role of ctDNA in disease monitoring. Recent publications include studies on the impact of postoperative venous thromboembolism, platinum resistance in ovarian carcinoma, and osteoporosis in cancer survivors.

Articles (11)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (2)

Abigail Cutler

Assistant Professor

University of Wisconsin-Madison

UNITED STATES

View details

Matthew Wagar

Assistant Professor

University of Virginia

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

ELLEN HARTENBACH

Research Interests

Make your next move.

Explore related searches

About

Articles (11)

Durvalumab plus carboplatin/paclitaxel followed by durvalumab as first-line treatment for endometrial cancer: patient-reported outcomes in the DUO E/GOG-3041/ENGOT-EN10 intent-to-treat and mismatch repair deficient populations

Dobbs Revisited - Addressing Effects on Resident Training in Obstetrics and Gynecology

Incidence of postoperative venous thromboembolism in patients with vulvar carcinoma undergoing vulvectomy with or without lymphadenectomy

TP53 mutations and the association with platinum resistance in high grade serous ovarian carcinoma

Beyond post-operative readmissions: analysis of the impact of unplanned readmissions during primary treatment of advanced-stage epithelial ovarian cancer on long-term oncology outcome

Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study

The role of ctDNA in endometrial cancer: A tool for risk stratification and disease monitoring

Opportunistic osteoporosis screening using routine computed tomography images to identify bone loss in gynecologic cancer survivors

Bone health and osteoporosis screening in gynecologic cancer survivors

Postoperative venous thromboembolism in gynecologic oncology patients undergoing minimally invasive surgery: Does modality matter?

Top Ten Tips Palliative Care Clinicians Should Know about Caring for Patients with Cervical Cancer

Collaborators (2)

Abigail Cutler

Matthew Wagar

Make your next move.